MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2

MLA

Xiefeng Wang, et al. “MiR-181d Acts as a Tumor Suppressor in Glioma by Targeting K-Ras and Bcl-2.” Journal of Cancer Research and Clinical Oncology, vol. 138, Dec. 2011, pp. 573–84. EBSCOhost, https://doi.org/10.1007/s00432-011-1114-x.

APA

Xiefeng Wang, Ning Liu, Junxia Zhang, Yongping You, Lei Cao, Yingyi Wang, Tao Jiang, Xi-Rui Wang, Chunsheng Kang, Hui Luo, Yu Yin, & Zhumei Shi. (2011). MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2. Journal of Cancer Research and Clinical Oncology, 138, 573–584. https://doi.org/10.1007/s00432-011-1114-x

Chicago

Xiefeng Wang, Ning Liu, Junxia Zhang, Yongping You, Lei Cao, Yingyi Wang, Tao Jiang, et al. 2011. “MiR-181d Acts as a Tumor Suppressor in Glioma by Targeting K-Ras and Bcl-2.” Journal of Cancer Research and Clinical Oncology 138 (December): 573–84. doi:10.1007/s00432-011-1114-x.